Corrigendum to: Direct Oral Anticoagulants Are a Potential Alternative to Low-Molecular-Weight Heparin for Thromboprophylaxis in Trauma Patients Sustaining Lower Extremity Fractures

[Journal of Surgical Research 258 (2020) 324-331]
      The authors regret an error in Table 4 stating that the primary outcome of total in-hospital symptomatic venous thromboembolic events occurred in 0.4% of patients receiving low-molecular-weight heparin. The correct symptomatic venous thromboembolism rate in low-molecular-weight heparin patients in this cohort was 1.4%, equal to the symptomatic venous thromboembolism rate in patients receiving direct oral anticoagulants, as was correctly reported in the text.
      The authors would like to apologise for any inconvenience caused.

      Linked Article